Testosterone therapy in focus amid policy debates and health findings
[Synopsis here]
Researchers at the University of Edinburgh have identified distinct androgen profiles in women with endometriosis, suggesting a non-invasive blood test could diagnose the condition and cut the current nine-year average wait in the UK. The study analysed 11-oxygenated androgens, including 11-ketotestosterone, in blood samples from 159 diagnosed patients and 57 controls, achieving over 95% accuracy in identifying cases.
Vivani Medical is developing a long-acting semaglutide implant to deliver GLP-1 therapy over months, potentially replacing injections. Novo Nordisk is evaluating the device to improve adherence and reduce weight regain, but regulatory and cost questions remain as trials proceed.
The Pentagon has rolled out annual testosterone screenings for service members aged 30 and older, with younger troops able to volunteer. Officials describe the measure as part of maintaining a “strong, resilient and capable” fighting force, while experts warn on possible health risks and ethical concerns about medical oversight.
Defense Secretary Pete Hegseth has announced a testosterone screening program for service members, extending annual checks to those 30 and older while offering voluntary testing for those under 30. Treatment remains voluntary, framed as restoring natural health rather than artificial enhancement. The move follows broader debates around testosterone policy in the administration.
The military is screening for low testosterone and offering therapy to qualified troops. Experts warn against overprescribing and emphasize that treatment targets those with clinically diagnosed deficiencies.
The military is implementing mandatory testosterone screening for troops aged 30 and older, aiming to optimize performance and longevity. Experts warn the policy lacks solid evidence and could pose health risks, particularly for women. Reports from multiple outlets highlight concerns about timing, medical guidelines, and potential overreach.
A string of developments around testosterone replacement therapy (TRT) has sparked a national conversation. The US military is considering testing service members’ testosterone levels and expanding access to TRT where clinically appropriate, while lawmakers and experts weigh safety, ethics and performance implications. Reports from AP News, CNBC, CNBC and other outlets indicate a widening trend in how TRT is discussed and regulated.
Federal officials are probing Denver Public Schools and Bethel School District to determine if they violated a federal privacy law giving parents the right to opt out of surveys on sexual behavior or attitudes. The Education Department says parents must decide on issues impacting their children’s intimate lives. In Denver, a teacher was placed on administrative leave and later fired after concerns raised in March 2025. Bethel District reports unapproved vials at a high school display and will cooperate with the investigation. Testosterone is prescribed for gender-affirming care.
Riders are facing checks over padded bras that could alter airflow, with the UCI enforcing rules on non-essential clothing. Updates cite race organisers' inspections ahead of time trials, and debates over potential advantages.
PMOS, previously grouped with PCOS, affects about 1 in 8 women and involves insulin resistance and testosterone imbalance. Case studies show GLP-1 medications may improve symptoms and menstrual regularity, with trials underway. Diagnosis remains challenging and access to new treatments will depend on healthcare systems.